May 16, 2024

CompassHER2 pCR trial to evaluate the HER2DXยฎ score

May 14, 2024

myeloMATCH, the next revolution in the NCI’s National Clinical Trials Network

May 14, 2024

Increasing inclusion and equity for Black women in breast cancer clinical trials (mentions EAZ171)

May 14, 2024

NCCN recommends universal testing for MSI and dMMR for all newly diagnosed gastric cancer patients

May 8, 2024

Press Release: ECOG-ACRIN adds another trial to the ComboMATCH precision oncology study platform

April 4, 2024

The Spring 2024 advocacy blog Considering Clinical Trials is now available

March 4, 2024

Press Release: NCI-MATCH cancer trial discovers a potentially broader role for an established dual HER2-blocking treatment

February 16, 2024

AACRโ€™s Clinical Cancer Research publishes a review article, โ€œTumor-Specific Activity of Precision Medicines in the NCI-MATCH Trialโ€

February 9, 2024

The January/February News from ECOG-ACRIN blog is now available

ECOG-ACRIN Cancer Research Group